• RIPostC, Ketone Bodies, and Ferroptosis After Stroke

  2026-09-17

  A 2024 ACS Chemical Neuroscience study identifies ketone body production as a mechanistic link between remote ischemic postconditioning and reduced ferroptotic injury after ischemic stroke. Its rat and HT22-cell experiments connect metabolic recovery with GPX4 preservation, ACSL4 suppression, improved mitochondrial structure, and reduced iron accumulation, providing a framework for testing 3-hydroxybutyrate and related ketone bodies in neuroprotection research.

• 3X FLAG Peptide: From Tag to Translational Tool

  2026-09-16

  A mechanistic and strategic guide to using the 3X (DYKDDDDK) Peptide in recombinant protein purification, immunodetection, structural biology, and translational assay development, with human SPFH complexes as an architecture-aware case study.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-09-16

  The 2024 Development study establishes SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary-cilium formation, neural progenitor survival, and brain development. By combining a mouse model with human SMPD4-deficient induced pluripotent stem cells and a ceramide-rescue experiment, the work connects SMPD4 loss to cerebellar hypoplasia, microcephaly-related phenotypes, and developmental brain disease.

• Oxaliplatin Workflows for DNA-Damage Research

  2026-09-15

  Build reproducible Oxaliplatin assays for DNA adduct formation, apoptosis, drug resistance, and tumor-model response. This practical guide combines solution handling, cell-based dose finding, mechanistic controls, and ABCB1-focused readouts to distinguish cytotoxicity from altered drug transport.

• Müller Cell PEDF Controls Retinal Neuron Survival

  2026-09-15

  The 2026 study by Younis and colleagues identifies Müller cells as an essential intermediary in angiopoietin-regulated retinal neuron survival. Its experiments connect Ang-1 and Ang-2 activity with Müller cell Tie-2/PI3K/Akt signaling, PEDF production, and PEDF-receptor-dependent neuronal protection, providing a mechanistic framework for retinal neurovascular research.

• Dasatinib Monohydrate Assay Guide

  2026-09-14

  Learn how Dasatinib Monohydrate, SKU B5954, can support reproducible kinase-inhibitor studies across viability, proliferation, cytotoxicity, and CML models. This scenario-based guide connects product formulation data with practical controls, concentration-response design, NET-related interpretation, and vendor-selection criteria.

• Decitabine as a Causality Probe in Gastric Cancer

  2026-09-14

  Decitabine (5-Aza-2'-deoxycytidine) can do more than reduce DNA methylation: it can help test whether infection-associated silencing of HNF4A is functionally linked to gastric cancer progression. This article presents a causality-focused framework for cancer epigenetics, tumor suppressor gene reactivation, and solid tumor epigenetic studies.

• SIRT1–PGC-1α–TFAM Signaling in Prion Stress

  2026-09-13

  Zhao et al. show that prion peptide-induced mitochondrial injury in N2a cells is associated with reduced SIRT1 abundance and activity, impaired mitochondrial biogenesis, and apoptosis. The study identifies a SIRT1–PGC-1α–TFAM pathway through which SIRT1 activation, including pharmacological activation by Resveratrol, can restore mitochondrial function in this cellular model.

• NADH as a Redox Decision Point in Cell Research

  2026-09-12

  NADH is more than an energy-transfer coenzyme: its relationship with NAD⁺ provides a framework for interpreting mitochondrial, metabolic, and disease-model data. This article translates NADH redox biology into practical assay decisions, controls, and research applications.

• Concanavalin A Targets Conserved Coronavirus Glycans

  2026-09-11

  Guo and colleagues identify two phylogenetically conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad antiviral vulnerability for concanavalin A. By combining fusion, pseudovirus, authentic-virus, biochemical, and mouse studies, the work links glycan recognition to impaired spike activation rather than rapidly evolving receptor-binding epitopes.

• CLK2 Drives Platinum Resistance in Ovarian Cancer

  2026-09-11

  A 2024 study identifies CLK2 as a functional determinant of platinum resistance in ovarian cancer, linking CLK2 activity to BRCA1 Ser1423 phosphorylation and enhanced DNA damage repair. The findings establish a preclinical rationale for investigating CLK2-directed strategies while highlighting the need to distinguish CLK2 biology from broader Cdc2-like kinase and splicing effects.

• Ibrutinib (PCI-32765): BTK Assay Design Guide

  2026-09-10

  Explore how Ibrutinib (PCI-32765) converts BTK biology into rigorous B-cell assays, from covalent pathway inhibition to CLL and autoimmune disease models. This guide also extracts transferable assay-design lessons from an Alzheimer’s disease study without conflating its findings with BTK pharmacology.

• Decitabine and HNF4A: Mapping Epigenetic Rescue

  2026-09-10

  Decitabine (5-Aza-2'-deoxycytidine) can do more than reduce methylation globally. This article shows how to use infection-linked HNF4A silencing as a model for designing locus-aware cancer epigenetics experiments and distinguishing tumor suppressor gene reactivation from nonspecific cytotoxicity.

• EPZ5676: From H3K79 Control to Immune Signaling

  2026-09-09

  Explore how EPZ5676, a highly selective DOT1L inhibitor, connects H3K79 methylation inhibition with leukemia biology and emerging innate immune mechanisms. This evidence-focused guide translates biochemical potency into better assay design while defining the limits of cross-disease interpretation.

• Trelagliptin, RUNX2, and Osteoblast Differentiation

  2026-09-09

  The reference study identifies a previously underexplored bone-related action of trelagliptin: promotion of osteoblastic differentiation and mineralization in MC3T3-E1 cells through an AMPK–RUNX2-associated mechanism. These findings connect a long-acting DPP-4 inhibitor used in type 2 diabetes treatment with a potential osteogenic application, while remaining preliminary because the work was conducted in a single in vitro model.

7988 records 1/533 page Next 12345 下5页 Last page